腾讯网

超过GPT-4V！AI 聊天机器人登上《自然》，肿瘤识别率接近 90%

当前，癌症已经成为全球人口死亡的主要原因之一，每年有数百万人死于癌症。世界卫生组织曾提出，三分之一的癌症可以通过早发现、早治疗得以治愈。 然而，癌症检查一直是医疗领域面临的一大难题，尤其在病理学分析中，精确识别和诊断肿瘤对于患者的 ...
腾讯网

哈佛、麻省推出面向医学多模态助手—PathChat

哈佛医学院、麻省理工学院、俄亥俄州立大学韦克斯纳医学等研究人员联合推出了，面向医学领域的多模态AI助手——PathChat。 PathChat不仅能理解、分析复杂的医学图像，还能基于多轮文本对话，为临床医生、医护人员提供精准和个性化的病理学指导。 为了提升 ...
36氪

超过 GPT-4V，哈佛医学院 AI 聊天机器人登上 Nature，肿瘤识别率接近 90%

WHO 表示，1/3 的癌症可以通过早发现、早治疗得以治愈。 当前，癌症已经成为全球人口死亡的主要原因之一，每年有数百万人死于癌症。世界卫生组织曾提出，三分之一的癌症可以通过早发现、早治疗得以治愈。 然而，癌症检查一直是医疗领域面临的一大难题 ...
VentureBeat

New medical LLM, PathChat 2, can talk to pathologists about tumors, offer diagnoses

Want smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now Four state-of-the-art large language models ...
Business Wire

Modella AI’s Generative AI Co-Pilot PathChat Receives FDA Breakthrough Device Designation

BOSTON--(BUSINESS WIRE)--Modella AI, a pioneer in generative and agentic artificial intelligence for biomedicine, is proud to announce that its cutting-edge generative AI co-pilot, PathChat DX, has ...
bernama

Modella AI’s PathChat Obtains FDA Breakthrough Device Designation For Advancing Pathology ...

PathChat 2a (research use only) is capable of patch, slide and case level reasoning. (Graphic: Business Wire) KUALA LUMPUR, Feb 3 (Bernama) -- Modella AI, a pioneer in generative and agentic ...
Business Wire

Techcyte and Modella AI Announce a Research Collaboration with Modella AI's State-of-the ...

OREM, Utah--(BUSINESS WIRE)--Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, today announced that its platform, Techcyte Fusion ™ (research use only ...
bernama

Modella AI’s PathChat Obtains FDA Breakthrough Device Designation For Advancing Pathology ...

KUALA LUMPUR, Feb 3 (Bernama) -- Modella AI, a pioneer in generative and agentic artificial intelligence (AI) for biomedicine, has announced that its cutting-edge generative AI co-pilot, PathChat DX, ...
Morningstar

Techcyte and Modella AI Announce a Research Collaboration with Modella AI's State-of-the ...

Techcyte and Modella AI Announce a Research Collaboration with Modella AI's State-of-the-Art Agentic and Generative AI-Powered Diagnostic Pathology Platform Techcyte, a leading provider of AI-powered ...